Mesoblast’s (MESO) “Overweight” Rating Reaffirmed at Piper Sandler
Piper Sandler reiterated their overweight rating on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report issued on Friday morning,Benzinga reports. Piper Sandler currently has a $24.00 price objective on the stock, up from their previous price objective of $15.00. Several other research analysts also recently commented on MESO. Cantor Fitzgerald upgraded Mesoblast to […]
Piper Sandler reiterated their overweight rating on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report issued on Friday morning,Benzinga reports. Piper Sandler currently has a $24.00 price objective on the stock, up from their previous price objective of $15.00. Several other research analysts also recently commented on MESO. Cantor Fitzgerald upgraded Mesoblast to […]
